Bank of Nova Scotia
GMED icon

Bank of Nova Scotia’s Globus Medical GMED Stock Holding History

Bank of Nova Scotia’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-265,101
Closed -$14.1M – 1022
2023
Q4 		$14.1M Buy
+265,101
New +$12.9M 0.03% 353
2023
Q2 		– Sell
-153,700
Closed -$8.71M – 1077
2023
Q1 		$8.71M Buy
+153,700
New +$9.86M 0.03% 300
2020
Q3 		– Sell
-8,824
Closed -$421K – 1030
2020
Q2 		$421K Buy
+8,824
New +$426K ﹤0.01% 797
2017
Q3 		– Sell
-68,859
Closed -$2.28M – 956
2017
Q2 		$2.28M Buy
+68,859
New +$2.16M 0.01% 595

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

Bank of Nova Scotia's GMED Position: Q1 2024 in Review

Bank of Nova Scotia sold out of Globus Medical (GMED) in Q1 2024, closing a stake of 265,101 shares — an estimated $14.1M sold.

Bank of Nova Scotia first reported a position in GMED in Q2 2017 and held it in 4 quarters. The position peaked at $14.1M in Q4 2023. 439 funds tracked by Wall St. Rank hold GMED as of Q1 2024.

  • Bank of Nova Scotia reported no remaining Globus Medical position as of Q1 2024 after selling out during the quarter.
  • Bank of Nova Scotia sold 265,101 Globus Medical shares in Q1 2024, an estimated $14.1M.
  • Bank of Nova Scotia first reported a position in Globus Medical in Q2 2017 and held it in 4 quarters.
  • Bank of Nova Scotia's Globus Medical position peaked at $14.1M in Q4 2023.
  • 439 funds tracked by Wall St. Rank held Globus Medical as of Q1 2024.

Based on Bank of Nova Scotia's 13F filing for Q1 2024, filed 15 May 2024.